Tymlos for the treatment of postmenopausal women with osteoporosis at high risk for fracture
The FDA ( US Food and Drug Administration ) has approved Tymlos ( Abaloparatide ) injection for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as history of ...
read article